Ocular Therapeutix, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $52.0M | $32.9M |
| FY2017 | — | $26.1M | $41.5M |
| FY2018 | — | $35.9M | $54.1M |
| FY2019 | — | $-3.6M | $54.4M |
| FY2020 | — | $76.1M | $228.1M |
| FY2021 | — | $88.0M | $164.2M |
| FY2022 | — | $35.4M | $102.3M |
| FY2023 | — | $91.1M | $195.8M |
| FY2024 | — | $315.3M | $392.1M |
| FY2025 | — | $654.3M | $737.1M |